๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Predicting Drug-Resistant Mutations of HIV Protease

โœ Scribed by Hiroshi Ishikita; Arieh Warshel


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
551 KB
Volume
47
Category
Article
ISSN
0044-8249

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


In vivo HIV-1 compartmentalisation: Drug
โœ Helen L. Devereux; Andy Burke; Christine A. Lee; Margaret A. Johnson ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB

## Abstract Four patients who had received highly active antiretroviral therapy (HAART), and had postmortem samples stored, were tested for genotypic resistance using consensus sequencing. One patient was further investigated using singleโ€copy sequencing. Patients 1, 3, and 4 showed a relatively un

ChemInform Abstract: Darunavir (I), a Co
โœ Arun K. Ghosh; Zachary L. Dawson; Hiroaki Mitsuya ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons โš– 18 KB ๐Ÿ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a โ€œFull Textโ€ option. The original article is trackable v

Diverse pattern of protease inhibitor re
โœ Veronica Svedhem; A. Lindkvist; T. Bergroth; Lidman Knut; A. Sรถnnerborg ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB

## Abstract The aim of the study was to describe the pattern of resistance mutations in human immunodeficiency virus type 1 (HIVโ€1) infected patients experiencing their first protease inhibitor (PI) failure on nelfinavir (NFV)โ€containing therapy. Earlier PIโ€naรฏve patients (nโ€‰=โ€‰172) with NFVโ€contain

Persistence of earlier HIV-1 drug resist
โœ Veronica Svedhem; Annica Lindkvist; Knut Lidman; Anders Sรถnnerborg ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB

## Abstract The objective was to study the persistence of drug resistance mutations detected earlier at virological failure during second or third line antiretroviral therapy. Therefore, in HIVโ€1 infected patients, with a virological treatment failure, genotypic resistance testing was carried out b